10/10/2023 | BKDD | Fitch puts Imperva on positive watch
|
8/1/2023 | BKDD | S&P puts Imperva on positive watch
|
5/2/2023 | BK | Moody’s alters Imperva view to negative
|
5/1/2023 | CLHY | Market Commentary: Imperva retreats with downgrade; Kenan revised; Allied, Life Time, Imperial Dade set talk
|
5/1/2023 | BK | Market Commentary: Imperva retreats with downgrade; Kenan revised; Allied, Life Time, Imperial Dade set talk
|
5/1/2023 | BKDD | S&P lowers Imperva
|
10/19/2022 | BK | Fitch moves Imperva view to negative
|
6/27/2022 | BK | S&P moves Imperva outlook to negative
|
10/28/2020 | CLHY | Market Commentary: Academy, Curium, Imperva, Xplornet, Angus Chemical break; E2open, MotorCity accelerated
|
10/28/2020 | BK | Market Commentary: Academy, Curium, Imperva, Xplornet, Angus Chemical break; E2open, MotorCity accelerated
|
10/28/2020 | BK | Imperva finalizes $147 million incremental term loan at 98.79 OID
|
10/26/2020 | BK | Imperva moves up deadline on $147 million incremental loan to Tuesday
|
10/20/2020 | CLHY | Market Commentary: Weber-Stephen, Russell tweak deals; TruGreen, Angus, Greystone, Highline, E2open set talk
|
10/20/2020 | BK | Market Commentary: Weber-Stephen, Russell tweak deals; TruGreen, Angus, Greystone, Highline, E2open set talk
|
10/20/2020 | BK | Imperva launches $147 million incremental term loan at 98.79-99 OID
|
10/19/2020 | CLHY | Market Commentary: Quirch, Mega Broadband break; Chobani tweaks deal; MultiPlan, Les Schwab and more set talk
|
10/19/2020 | BK | Market Commentary: Quirch, Mega Broadband break; Chobani tweaks deal; MultiPlan, Les Schwab and more set talk
|
10/19/2020 | BK | Imperva to launch $147 million incremental term loan on Tuesday
|
4/16/2020 | BK | Fitch trims Imperva
|
11/20/2018 | BK | Market Commentary: Rocket, Imperva, Hearthside, Office Depot, Evertec, MRO, Odyssey, Flynn and more break
|
11/20/2018 | CLHY | Market Commentary: Rocket, Imperva, Hearthside, Office Depot, Evertec, MRO, Odyssey, Flynn and more break
|
11/20/2018 | BK | Imperva updates first- and second-lien term loan pricing
|
11/14/2018 | BK | Moody's rates Imperva loans B2, Caa2
|
11/9/2018 | BK | Market Commentary: Information Resources breaks; Celestica, Talbots, Ring Container release deal updates
|
11/9/2018 | CLHY | Market Commentary: Information Resources breaks; Celestica, Talbots, Ring Container release deal updates
|
11/9/2018 | BK | Fitch rates Imperva loans B+, CCC+
|
11/9/2018 | BK | Imperva reveals price talk on first- and second-lien term loans
|
11/9/2018 | BK | S&P rates Imperva loans B-, CCC
|
11/7/2018 | BK | Market Commentary: PolyOne frees to trade atop OID; Information Resources, AssetMark, PetVet revise deals
|
11/7/2018 | CLHY | Market Commentary: PolyOne frees to trade atop OID; Information Resources, AssetMark, PetVet revise deals
|
11/7/2018 | BK | Imperva readies launch of $1.05 billion of term loans for Friday
|
10/10/2018 | BK | Imperva plans new debt financing for buyout by Thoma Bravo
|
11/9/2011 | PP | Imperva prices $85.5 million initial public offering of common stock
|